These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21457198)

  • 1. Spatial variation in incidence of nonmelanoma skin cancers.
    Verne J
    Br J Dermatol; 2011 Apr; 164(4):694-5. PubMed ID: 21457198
    [No Abstract]   [Full Text] [Related]  

  • 2. Geographical, urban/rural and socioeconomic variations in nonmelanoma skin cancer incidence: a population-based study in Ireland.
    Carsin AE; Sharp L; Comber H
    Br J Dermatol; 2011 Apr; 164(4):822-9. PubMed ID: 21291423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of nonmelanoma skin cancer in Ireland.
    Bennett M; Comber H; Deady S
    Br J Dermatol; 2013 Feb; 168(2):452. PubMed ID: 22835212
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence and risk factors for nonmelanoma skin cancer after heart transplantation.
    Molina BD; Leiro MG; Pulpón LA; Mirabet S; Yañez JF; Bonet LA; Vilchez FG; Delgado JF; Manito N; Rábago G; Arizón JM; Romero N; Roig E; Blasco T; Pascual D; de la Fuente L; Muñiz J
    Transplant Proc; 2010 Oct; 42(8):3001-5. PubMed ID: 20970593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors.
    Healy E; Collins P; Barnes L
    Ir Med J; 1995; 88(2):58-9. PubMed ID: 7775148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988-2007.
    Jung GW; Metelitsa AI; Dover DC; Salopek TG
    Br J Dermatol; 2010 Jul; 163(1):146-54. PubMed ID: 20645981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and economic burden of nonmelanoma skin cancer.
    Cakir BÖ; Adamson P; Cingi C
    Facial Plast Surg Clin North Am; 2012 Nov; 20(4):419-22. PubMed ID: 23084294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996.
    Harris RB; Griffith K; Moon TE
    J Am Acad Dermatol; 2001 Oct; 45(4):528-36. PubMed ID: 11568742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonmelanoma skin cancer.
    Katz MH
    Md Med J; 1997; 46(5):239-42. PubMed ID: 9159053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of nonmelanoma skin cancer.
    Urbach F
    Dermatol Clin; 1991 Oct; 9(4):751-5. PubMed ID: 1934649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of nonmelanoma skin cancer: a review.
    Corona R
    Ann Ist Super Sanita; 1996; 32(1):37-42. PubMed ID: 8804184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmelanoma skin cancer: today's epidemic.
    Limmer BL
    Tex Med; 2001 Feb; 97(2):56-8. PubMed ID: 11233060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of nonmelanoma skin cancer.
    Strom SS; Yamamura Y
    Clin Plast Surg; 1997 Oct; 24(4):627-36. PubMed ID: 9342506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
    Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
    Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative importance of risk factors in nonmelanoma carcinoma.
    Vitaliano PP; Urbach F
    Arch Dermatol; 1980 Apr; 116(4):454-6. PubMed ID: 7369779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies in the public health approach to keratinocyte carcinomas.
    Weinstock MA
    Br J Dermatol; 2006 May; 154 Suppl 1():3-4. PubMed ID: 16712708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrition and nonmelanoma skin cancers.
    Payette MJ; Whalen J; Grant-Kels JM
    Clin Dermatol; 2010; 28(6):650-62. PubMed ID: 21034989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.